Comprehensive Financial Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.13M Hold
2,207,619
0.14% 20
2026
Q1
$8.57M Hold
2,207,619
0.28% 15
2025
Q4
$4.3M Hold
2,207,619
0.13% 18
2025
Q3
$1.87M Hold
2,207,619
0.05% 25
2025
Q2
$1.6M Hold
2,207,619
0.04% 29
2025
Q1
$1.9M Hold
2,207,619
0.06% 22
2024
Q4
$3.71M Sell
2,207,619
-1
-0% -$2 0.1% 16
2024
Q3
$6.29M Hold
2,207,620
0.18% 16
2024
Q2
$5.17M Buy
2,207,620
+1
+0% +$3 0.18% 16
2024
Q1
$6.49M Hold
2,207,619
0.21% 16
2023
Q4
$6.6M Hold
2,207,619
0.23% 14
2023
Q3
$6.98M Hold
2,207,619
0.25% 15
2023
Q2
$8.54M Sell
2,207,619
-17,000
-0.8% -$49K 0.28% 12
2023
Q1
$6.16M Hold
2,224,619
0.19% 14
2022
Q4
$4M Hold
2,224,619
0.13% 19
2022
Q3
$4.72M Hold
2,224,619
0.12% 18
2022
Q2
$5.98M Hold
2,224,619
0.17% 17
2022
Q1
$9.65M Hold
2,224,619
0.17% 15
2021
Q4
$11.5M Hold
2,224,619
0.15% 17
2021
Q3
$13.7M Hold
2,224,619
0.13% 14
2021
Q2
$22.5M Buy
+2,224,619
New +$24.1M 0.19% 15

Other funds holding NAUT

Comprehensive Financial Management's NAUT Position: Q2 2026 in Review

Comprehensive Financial Management held its Nautilus Biotechnolgy (NAUT) position steady in Q2 2026 at 2,207,619 shares worth $4.13M. The position accounts for 0.14% of the portfolio, ranked #20.

Comprehensive Financial Management first reported a position in NAUT in Q2 2021 and has held it in 21 quarters since. The position peaked at $22.5M in Q2 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Comprehensive Financial Management held 2,207,619 shares of Nautilus Biotechnolgy worth $4.13M as of Q2 2026.
  • Comprehensive Financial Management left its Nautilus Biotechnolgy share count unchanged in Q2 2026.
  • Nautilus Biotechnolgy made up 0.14% of Comprehensive Financial Management's portfolio in Q2 2026, its #20 holding.
  • Comprehensive Financial Management first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 21 quarters since.
  • Comprehensive Financial Management's Nautilus Biotechnolgy position peaked at $22.5M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Comprehensive Financial Management's 13F filing for Q2 2026, filed 14 Aug 2026.